April 11, 2022, Jiangxi, China, Faced with the severe and completed epidemic situation in China, Jiangling Motors, as an important manufacturer of nucleic acid sampling vehicle, medical vehicle, vaccine cold-chain vehicle, sterilization and disinfection vehicle, isolation transfer vehicle, and epidemic prevention vehicle, is making every effort to organize employees, and produce more ambulances and anti-epidemic vehicles to fight against the epidemic.
 

As the largest negative pressure ambulance manufacturer in China, Jiangling Motors has supplied more than 10,000 anti-epidemic vehicles of various types in 2020, accounting for more than 70% in the market.

From January to March 2022, Jiangling received more than 5,100 orders for  ambulances and anti-epidemic vehicles. Under the condition of full production, Jiangling Motors has delivered more than 3,600 units ambulances since March. It is expected that all the ambulances will be offline in early April and be delivered to the front line of epidemic prevention as soon as possible after modification.